C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer
| Autor(en): | Schlotter, C. M. Vogt, U. Bosse, U. Mersch, Berthold Waβmann, Katja |
Stichwörter: | Internal medicine; Oncology; Breast cancer; Biology; Ecology; Univariate analysis; Tamoxifen; Multivariate analysis; Grading (engineering); Medicine; Cyclophosphamide; Chemotherapy; Epirubicin; Surgical oncology; Trastuzumab; Cancer | Erscheinungsdatum: | 2003 | Volumen: | 5 | Ausgabe: | 2 | DOI: | https://doi.org/10.1186/bcr568 |
Zur Langanzeige
